» Articles » PMID: 11134021

Tamm-Horsfall Protein Binds to Type 1 Fimbriated Escherichia Coli and Prevents E. Coli from Binding to Uroplakin Ia and Ib Receptors

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Jan 13
PMID 11134021
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

The adherence of uropathogenic Escherichia coli to the urothelial surface, a critical first step in the pathogenesis of urinary tract infection (UTI), is controlled by three key elements: E. coli adhesins, host receptors, and host defense mechanisms. Although much has been learned about E. coli adhesins and their urothelial receptors, little is known about the role of host defense in the adherence process. Here we show that Tamm-Horsfall protein (THP) is the principal urinary protein that binds specifically to type 1 fimbriated E. coli, the main cause of UTI. The binding was highly specific and saturable and could be inhibited by d-mannose and abolished by endoglycosidase H treatment of THP, suggesting that the binding is mediated by the high-mannose moieties of THP. It is species-conserved, occurring in both human and mouse THPs. In addition, the binding to THP was much greater with an E. coli strain bearing a phenotypic variant of the type 1 fimbrial FimH adhesin characteristic of those prevalent in UTI isolates compared with the one prevalent in isolates from the large intestine of healthy individuals. Finally, a physiological concentration of THP completely abolished the binding of type 1 fimbriated E. coli to uroplakins Ia and Ib, two putative urothelial receptors for type 1 fimbriae. These results establish, on a functional level, that THP contains conserved high-mannose moieties capable of specific interaction with type 1 fimbriae and strongly suggest that this major urinary glycoprotein is a key urinary anti-adherence factor serving to prevent type 1 fimbriated E. coli from binding to the urothelial receptors.

Citing Articles

Tamm-Horsfall protein augments neutrophil NETosis during urinary tract infection.

Mercado-Evans V, Branthoover H, Chew C, Serchejian C, Saltzman A, Mejia M JCI Insight. 2024; 10(1.

PMID: 39589812 PMC: 11721310. DOI: 10.1172/jci.insight.180024.


A zebrafish gene with sequence similarities to human uromodulin and GP2 displays extensive evolutionary diversification among teleost and confers resistance to bacterial infection.

Naruoka S, Sakata S, Kawabata S, Hashiguchi Y, Daikoku E, Sakaguchi S Heliyon. 2024; 10(18):e37510.

PMID: 39309883 PMC: 11415648. DOI: 10.1016/j.heliyon.2024.e37510.


Advances in uromodulin biology and potential clinical applications.

Nanamatsu A, de Araujo L, LaFavers K, El-Achkar T Nat Rev Nephrol. 2024; 20(12):806-821.

PMID: 39160319 PMC: 11568936. DOI: 10.1038/s41581-024-00881-7.


The Molecular Mechanisms and Therapeutic Potential of Cranberry, D-Mannose, and Flavonoids against Infectious Diseases: The Example of Urinary Tract Infections.

Ioannou P, Baliou S Antibiotics (Basel). 2024; 13(7).

PMID: 39061275 PMC: 11273536. DOI: 10.3390/antibiotics13070593.


Molecular Characterization of High and Low Virulent Clinical Strains Isolated from Patients with Urinary Tract Infections with or without Bacteremia in Southern Taiwan.

Hsiao C, Lee Y, Shyu D, Su C, Lin M, Guo N Infect Drug Resist. 2024; 17:2389-2399.

PMID: 38903152 PMC: 11186960. DOI: 10.2147/IDR.S458925.